Literature DB >> 11689286

Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors.

Y Takebayashi1, K Nakayama, A Kanzaki, H Miyashita, O Ogura, S Mori, M Mutoh, K Miyazaki, M Fukumoto, Y Pommier.   

Abstract

The deficiencies of nucleotide excision repair (NER) factors are genetic diseases, xeroderma pigmentosum (XP) increasing risk of developing cancer on sun-exposed areas of the skin. However, the abnormality of NER factors in human sporadic carcinoma remains unclear. Loss of heterozygosity (LOH) analysis for the XP, XPA, XPB, XPC, XPD, XPE, XPF, XPG and the transcription-coupled repair factor, Cockayne syndrome B (CSB) revealed that NER factors were abnormal in 62.1 % of ovarian tumors (18/29), 16.7% of colon (2/12) and 22.2% lung (2/9) carcinomas. Furthermore, 13.8% of ovarian, 8.3% of colon and 22% of lung carcinomas exhibited LOH for NER factors without LOH for tumor suppressor genes such as p53, FHIT, APC, BRCAI, BRCA2 and DCC. Although both microsatellite instability and LOH of NER factors were observed in some cases, there was no strong association between them in the present study. These observations raise the possibility that alterations of NER factors may be frequent in human sporadic carcinomas. Further study should be needed to find the direct evidence of NER gene abnormalities in human sporadic carcinoma tissues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689286     DOI: 10.1016/s0304-3835(01)00690-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation.

Authors:  Gan Wang; Lynn Chuang; Xiaohong Zhang; Stephanie Colton; Alan Dombkowski; John Reiners; Amy Diakiw; Xiaoxin Susan Xu
Journal:  Nucleic Acids Res       Date:  2004-04-23       Impact factor: 16.971

2.  Impairment of alveolar macrophage transcription in idiopathic pulmonary fibrosis.

Authors:  Ping Ren; Ivan O Rosas; Sandra D Macdonald; Hai-Ping Wu; Eric M Billings; Bernadette R Gochuico
Journal:  Am J Respir Crit Care Med       Date:  2007-03-01       Impact factor: 21.405

3.  Deficiency of DNA repair nuclease ERCC1-XPF promotes prostate cancer progression in a tissue recombination model.

Authors:  Derek J Matoka; Veronica Yao; Diana S Harya; Jennifer L Gregg; Andria R Robinson; Laura J Niedernhofer; Anil V Parwani; Christoph Maier; Dean J Bacich
Journal:  Prostate       Date:  2011-12-27       Impact factor: 4.104

4.  XPC codon 939 polymorphism is associated with susceptibility to DNA damage induced by aflatoxin B1 exposure.

Authors:  Xi-Dai Long; Hong-Dong Huang; Xiao-Ying Huang; Jin-Guang Yao; Qiang Xia
Journal:  Int J Clin Exp Med       Date:  2015-01-15

5.  Clinicopathological significance and prognostic value of Xeroderma pigmentosum complementary group C (XPC) expression in sporadic breast cancer patients.

Authors:  Xuefeng Bai; Feng Jin; Yingzi Fu; Zhaojin Yu; Lin Zhao; Jie Ren; Yanlin Li; Xuyang Jiao; Haishan Zhao; Weifan Yao; Xiaoyi Mi; Enhua Wang; Olufunmilayo I Olopade; Mingyi Zhou; Minjie Wei
Journal:  Med Oncol       Date:  2011-10-30       Impact factor: 3.064

6.  Role of DNA repair gene polymorphisms in the efficiency of platinum-based adjuvant chemotherapy for non-small cell lung cancer.

Authors:  Juliette Mathiaux; Valérie Le Morvan; Marina Pulido; Jacques Jougon; Hugues Bégueret; Jacques Robert
Journal:  Mol Diagn Ther       Date:  2011-06-01       Impact factor: 4.074

7.  Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis.

Authors:  Ai-Wen Wu; Jin Gu; Jia-Fu Ji; Zhen-Fu Li; Guang-Wei Xu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

8.  DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.

Authors:  Nilotpal Roy; Prashant V Bommi; Uppoor G Bhat; Shaumick Bhattacharjee; Indira Elangovan; Jing Li; Krushna C Patra; Dragana Kopanja; Adam Blunier; Richard Benya; Srilata Bagchi; Pradip Raychaudhuri
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

Review 9.  BRCA1 and p53: compensatory roles in DNA repair.

Authors:  Anne-Renee Hartman; James M Ford
Journal:  J Mol Med (Berl)       Date:  2003-09-09       Impact factor: 4.599

10.  Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk.

Authors:  Jing Shen; Marilie D Gammon; Mary Beth Terry; Susan L Teitelbaum; Sybil M Eng; Alfred I Neugut; Regina M Santella
Journal:  Eur J Cancer       Date:  2007-11-28       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.